Skip to main content
Pharma's development races are heating up

Big pharma is nearing important milestones in the race to develop and market the next blockbuster anti-inflammatory drug, gene therapies for Duchenne muscular dystrophy and new treatments for spinal muscular atrophy. Biotechs are looking for new treatments for nonalcoholic steatohepatitis, and three experimental therapies are vying to become the first gene therapy to cure hemophilia A.

Full Story: